Mount Yale Investment Advisors’s ANI Pharmaceuticals ANIP Stock Holding History

Mount Yale Investment Advisors’s Portfolio ANIP Stock Details ANIP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$273K	Buy	+3,556	New	+$278K	0.01%	936
2025 Q3	–	Sell	-3,760	Closed	-$245K	–	718
2025 Q2	$245K	Buy	+3,760	New	+$245K	0.02%	511
2018 Q4	–	Sell	-1,879	Closed	-$104K	–	339
2018 Q3	$104K	Buy	1,879 +129	+7%	+$7.89K	0.02%	427
2018 Q2	$117K	Hold	1,750	–	–	0.02%	411
2018 Q1	$102K	Buy	+1,750	New	+$111K	0.02%	444

Other funds holding ANIP

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

SCM

Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

TCM

Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return

GAM

Goldentree Asset Management New York $1.69B AUM 10.69% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Mount Yale Investment Advisors's ANIP Position: Q1 2026 in Review

Mount Yale Investment Advisors opened a new position in ANI Pharmaceuticals (ANIP) in Q1 2026: 3,556 shares worth $273K. The stake represents 0.01% of the portfolio and ranks #936 among its holdings. This is a return to the name: Mount Yale Investment Advisors previously reported a position in ANIP as recently as Q2 2025.

Mount Yale Investment Advisors first reported a position in ANIP in Q1 2018 and has held it in 5 quarters since. 280 funds tracked by Wall St. Rank hold ANIP as of Q1 2026.

Mount Yale Investment Advisors held 3,556 shares of ANI Pharmaceuticals worth $273K as of Q1 2026.
ANI Pharmaceuticals was a new Mount Yale Investment Advisors position in Q1 2026.
ANI Pharmaceuticals made up 0.01% of Mount Yale Investment Advisors's portfolio in Q1 2026, its #936 holding.
Mount Yale Investment Advisors first reported a position in ANI Pharmaceuticals in Q1 2018 and has held it in 5 quarters since.
280 funds tracked by Wall St. Rank held ANI Pharmaceuticals as of Q1 2026.

Based on Mount Yale Investment Advisors's 13F filing for Q1 2026, filed 27 Apr 2026.